Jinyang Pharm's anti-SARS therapy is spotlighted in Southeast markets

As the outbreak of severe acute respiratory syndrome is hitting the Southeast regions, Jinyang Pharm's combination therapy of ribavirin plus steroid preparations there has been popular in the treatment of SARS and hepatitis C.

According to Jinyang Pharm, the first shipment of ribavirin towards Miyanma was made available after successful registration on Septebmer 10, 2002, followed by the se...